EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical and Patient-Reported Outcomes in C-POST: Phase 3 Trial of Adjuvant Cemiplimab versus Placebo for High-Risk Cutaneous Squamous Cell Carcinoma

D. Rischin, C.-I. Chen, S. Porceddu, F. Day, D.P. Brungs, H. Christie, J.E. Jackson, B.N. Stein, Y.B. Su, R. Ladwa, S.E. Bowyer, Z. Otty und 19 weitere

EJC Skin Cancer · 2026 · 4 · 100962

DOI: 10.1016/j.ejcskn.2026.100962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EJC Skin Cancer, 2026. Verfasst von D. Rischin und 30 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rischin, D., Chen, C., Porceddu, S., Day, F., Brungs, D., Christie, H., Jackson, J., Stein, B., Su, Y., Ladwa, R., Bowyer, S., Otty, Z., Yamazaki, N., Bossi, P., Challapalli, A., Hauschild, A., Schurman, M. D. L. V., Queirolo, P., Cañueto, J., …, & Lim, A. (2026). Clinical and Patient-Reported Outcomes in C-POST: Phase 3 Trial of Adjuvant Cemiplimab versus Placebo for High-Risk Cutaneous Squamous Cell Carcinoma. EJC Skin Cancer, 4, 100962. https://doi.org/10.1016/j.ejcskn.2026.100962

Vancouver

Rischin D, Chen C, Porceddu S, Day F, Brungs D, Christie H, et al. Clinical and Patient-Reported Outcomes in C-POST: Phase 3 Trial of Adjuvant Cemiplimab versus Placebo for High-Risk Cutaneous Squamous Cell Carcinoma. EJC Skin Cancer. 2026;4:100962. doi:10.1016/j.ejcskn.2026.100962

BibTeX
@article{Rischin2026,
  author = {Rischin, D. and Chen, C.-I. and Porceddu, S. and Day, F. and Brungs, D.P. and Christie, H. and Jackson, J.E. and Stein, B.N. and Su, Y.B. and Ladwa, R. and Bowyer, S.E. and Otty, Z. and Yamazaki, N. and Bossi, P. and Challapalli, A. and Hauschild, A. and Schurman, M. De Liz Vassen and Queirolo, P. and Cañueto, J. and Silva, F.A. Ferreira da and Stratigos, A. and Guminski, A. and Bansal, S. and Joseph, C. and Seebach, F. and Yoo, S.-Y. and Harnett, J. and Chi, L. and Goncalves, P. and Fury, M.G. and Lim, A.M.},
  title = {Clinical and Patient-Reported Outcomes in C-POST: Phase 3 Trial of Adjuvant Cemiplimab versus Placebo for High-Risk Cutaneous Squamous Cell Carcinoma},
  journal = {EJC Skin Cancer},
  year = {2026},
  volume = {4},
  pages = {100962},
  doi = {10.1016/j.ejcskn.2026.100962}
}
Kostenlos starten →